In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...